Does new onset and pre-existing atrial fibrillation predict mortality in COVID-19 patients?
Yazarlar (9)
Selim Aydemir Türkiye
Emrah Aksakal Sağlık Bilimleri Üniversitesi, Türkiye
Faruk Aydınyılmaz
Türkiye
Türkiye
Doç. Dr. Oktay Gülcü Türkiye
İbrahim Saraç Atatürk Üniversitesi, Türkiye
Sidar Şiyar Aydın Atatürk Üniversitesi, Türkiye
Remziye Doğan Türkiye
Dr. Öğr. Üyesi Merve LAZOĞLU Türkiye
Prof. Dr. Kamuran Kalkan Sağlık Bilimleri Üniversitesi, Türkiye
| Makale Türü |
Özgün Makale
(ESCI dergilerinde yayınlanan tam makale)
|
||
| Dergi Adı | The Egyptian Heart Journal | ||
| Dergi ISSN | 2090-911X Dergi Bilgileri (2022) | ||
| Dergi Tarandığı Indeksler | ESCI | ||
| Makale Dili | İngilizce | Basım Tarihi | 07-2022 |
| Kabul Tarihi | 24-06-2022 | Yayınlanma Tarihi | 07-07-2022 |
| Cilt / Sayı / Sayfa | 74 / 0 / – | DOI | 10.1186/s43044-022-00291-9 |
| Makale Linki | http://dx.doi.org/10.1186/s43044-022-00291-9 | ||
| UAK Araştırma Alanları |
Kardiyoloji
|
||
| Özet |
| Coronavirus Disease-2019 (COVID-19), caused by Severe Acute Respiratory Syndrome-Coronavirus-2, still remains prevalent and severe. We aimed to evaluate the effects of pre-existing atrial fibrillation and new-onset atrial fibrillation (NOAF) on the clinical severity and mortality of COVID-19. Between April and December 2020, 5577 patients with positive PCR and/or COVID-19 compatible findings in computed tomography hospitalized were enrolled retrospectively. Total and in-hospital mortality, need for intensive care unit (ICU), need for mechanical ventilation, and recurrent hospitalization results of 286 patients with pre-existing AF before hospitalization and 82 patients with NOAF during hospitalization were evaluated. Preexisting AF was associated with a 2-fold increase in total and in-hospital mortality [OR (2.16 (1.62-2.89), 2.02 (1.48-2.76), P < 0.001, respectively]. NOAF was associated with a 14-fold increase in total mortality and a 12-fold increase in in-hospital mortality [OR(14.72 (9.22-23.5), 12.56 (8.02-19.68), P < 0.001], respectively]. However, pre-existing AF and NOAF resulted in increased ICU admission, mechanical ventilation, and recurrent hospitalization. In the Cox regression analysis, NOAF was observed as an independent risk factor for mortality. Pre-existing AF and in-hospital NOAF were associated with increased mortality and severity in hospitalized COVID-19 patients. In addition, NOAF was observed as an independent prognostic indicator in terms of total mortality. |
| Anahtar Kelimeler |
| Atrial fibrillation | COVID-19 | Mortality |
BM Sürdürülebilir Kalkınma Amaçları
| Atıf Sayıları | |
| Yöksis | 9 |
| PubMed | 9 |